Hello, I have read some papers about hematologic malignancies. And, I wondered why investigators compare short-term infusion and continuous infusion during phase I study.
And also, I wondered why they use 'peripheral blast' and 'bone marrow blast' to check the effects of drug. (before and after)
Please explain. Thank you!